Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
129.83
-5.01 (-3.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,935,369
Open
134.02
Bid (Size)
129.80 (200)
Ask (Size)
130.10 (400)
Prev. Close
134.84
Today's Range
129.26 - 134.97
52wk Range
107.75 - 157.29
Shares Outstanding
1,253,809,440
Dividend Yield
2.53%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What's going on in today's session: S&P500 movers
↗
Today 12:35 EDT
Via
Chartmill
2 Recession-Resistant Dividend Stocks to Buy and Hold
↗
Today 12:20 EDT
You don't need to predict a recession to prepare your portfolio. These two stocks can help.
Via
The Motley Fool
Topics
Economy
Performance
YTD
+6.8%
+6.8%
1 Month
+3.5%
+3.5%
3 Month
-8.6%
-8.6%
6 Month
+7.6%
+7.6%
1 Year
+14.7%
+14.7%
More News
Read More
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?
↗
Today 7:01 EDT
Via
The Motley Fool
Topics
ETFs
Gilead Sciences Inc (NASDAQ:GILD): A Sustainable Dividend Leader in the Biotechnology Sector
↗
June 29, 2026
Via
Chartmill
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
Stay informed with the top movers within the S&P500 index on Tuesday.
↗
July 07, 2026
Via
Chartmill
Generic Fears Overdone? Gilead Stock Has More Room to Run, Analyst Says
↗
July 06, 2026
Via
Benzinga
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
July 06, 2026
Via
Investor Brand Network
FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?
↗
July 04, 2026
Via
The Motley Fool
Topics
ETFs
If You Invested $1000 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today
↗
July 03, 2026
Via
Benzinga
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns
↗
July 02, 2026
Via
The Motley Fool
Topics
ETFs
Gilead's Trodelvy Expands Reach With New FDA Approval In Breast Cancer
↗
June 25, 2026
Via
Benzinga
This ETF Has More Than Doubled the S&P 500's Returns Over the Past Decade. Is It a Buy for the Next Decade?
↗
June 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Stocks
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
June 24, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026
Via
Investor Brand Network
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
June 24, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.
↗
June 23, 2026
Via
MarketBeat
Topics
ETFs
European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors
June 23, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026
From
BioMedWire
Via
GlobeNewswire
3 S&P 500 Stocks with Exciting Potential
June 23, 2026
Via
StockStory
Topics
Stocks
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q1 Earnings?
June 18, 2026
Via
StockStory
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
↗
June 17, 2026
Via
Benzinga
1 Cash-Producing Stock Worth Investigating and 2 We Brush Off
June 17, 2026
Via
StockStory
U.S. FDA Accepts Gilead’s Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention
June 15, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 129.83
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 07/10/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 162.78B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 163B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today